Genetic Technologies (AU:GTG) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Genetic Technologies Limited has announced an extension to the voluntary suspension of its securities as it finalizes funding agreements crucial for its Entitlement Offer and a strategic distribution partnership. This move comes as the company seeks to strengthen its financial standing and market presence in genomics-based health solutions. The suspension is expected to last until November 4, 2024, unless an earlier update is provided.
For further insights into AU:GTG stock, check out TipRanks’ Stock Analysis page.